Product Management

Engineering

Education

Military and Protective Services

Business Development

Arts and Design

Administrative

Research

Accounting

Entrepreneurship

AI platform for medicinal chemistry and drug discovery

CEO & Co-Founder

PostEra’s Fertility programs acquired by EMD Serono, Inc.

HOF Capital Portfolio

Enamine contributes to the discovery of promising broad-spectrum coronavirus antiviral

PostEra Announces a Research Collaboration with Amgen to Discover Small Molecule Therapeutics using Artificial Intelligence

Machine Learning Researcher - Agentic Science

PostEra is an AI-first biotech company developing AI systems to accelerate medicine discovery. The Machine Learning Researcher will develop agentic systems and machine learning methods for biochemical modeling, biological data analysis, molecular and tabular in-context learning, and foundation models, while translating research into tools for drug discovery scientists.

General Interest

PostEra is building a modern biopharma utilizing their AI platform, Proton, to accelerate medicinal chemistry and new medicine discovery. They focus on Women's Health and Reproductive Medicine while fostering partnerships with biopharma, and they are actively involved in open-science initiatives for pandemic preparedness.